RXDX Annual Shareholders Equity
$675.97 M
+$440.81 M+187.46%
31 December 2022
Summary:
As of February 5, 2025, RXDX annual stockholders equity is $675.97 million, with the most recent change of +$440.81 million (+187.46%) on December 31, 2022. During the last 3 years, it has risen by +$712.94 million (+1928.52%).RXDX Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RXDX Quarterly Shareholders Equity
$697.62 M
+$21.65 M+3.20%
31 March 2023
Summary:
As of February 5, 2025, RXDX quarterly stockholders equity is $697.62 million, with the most recent change of +$21.65 million (+3.20%) on March 31, 2023. Over the past year, it has increased by +$490.89 million (+237.46%).RXDX Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RXDX Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +187.5% | +237.5% |
| 3 y3 years | +1928.5% | - |
| 5 y5 years | +1928.5% | - |
RXDX Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | at high | at high |
Prometheus Biosciences Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $697.62 M(+3.2%) |
| Dec 2022 | $675.97 M(+187.5%) | $675.97 M(+190.7%) |
| Sept 2022 | - | $232.53 M(+21.2%) |
| June 2022 | - | $191.83 M(-7.2%) |
| Mar 2022 | - | $206.72 M(-12.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $235.16 M(-341.1%) | $235.16 M(-10.3%) |
| Sept 2021 | - | $262.10 M(-7.2%) |
| June 2021 | - | $282.43 M(-5.9%) |
| Mar 2021 | - | $300.20 M(-407.8%) |
| Dec 2020 | -$97.54 M(+163.9%) | -$97.54 M |
| Dec 2019 | -$36.97 M | - |
FAQ
- What is Prometheus Biosciences annual stockholders equity?
- What is the all time high annual shareholders equity for Prometheus Biosciences?
- What is Prometheus Biosciences annual shareholders equity year-on-year change?
- What is Prometheus Biosciences quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Prometheus Biosciences?
- What is Prometheus Biosciences quarterly shareholders equity year-on-year change?
What is Prometheus Biosciences annual stockholders equity?
The current annual shareholders equity of RXDX is $675.97 M
What is the all time high annual shareholders equity for Prometheus Biosciences?
Prometheus Biosciences all-time high annual stockholders equity is $675.97 M
What is Prometheus Biosciences annual shareholders equity year-on-year change?
Over the past year, RXDX annual stockholders equity has changed by +$440.81 M (+187.46%)
What is Prometheus Biosciences quarterly stockholders equity?
The current quarterly shareholders equity of RXDX is $697.62 M
What is the all time high quarterly shareholders equity for Prometheus Biosciences?
Prometheus Biosciences all-time high quarterly stockholders equity is $697.62 M
What is Prometheus Biosciences quarterly shareholders equity year-on-year change?
Over the past year, RXDX quarterly stockholders equity has changed by +$490.89 M (+237.46%)